Advancing Diabetes Quality Measurement in the Era of Continuous Glucose Monitoring. Issue 2 (April 2023)

• Record Type: Journal Article
• Authors: Khan, Maliha; Wahid, Naila; Musser, Taylor; Bergenstal, Richard M.; Ebekozien, Osagie; Snow, Kenneth; Thomas, Kate; Aprigliano, Christel
• Is Part Of: Science of diabetes self-management and care. Volume 49:Issue 2(2023)
• Page Start: 112
• Page End: 125
• Publication Date: 2023-04
• Subjects: Diabetes -- Study and teaching -- Periodicals; Patient education -- Periodicals; 616.4620071
• DOI: 10.1177/26350106231163518
• Languages: English
• ISSNs: 2635-0114

Abstract

Purpose: The purpose of this research is to develop a set of continuous glucose monitoring (CGM)-related measure concepts to be tested in a health care system. Existing measures assessing the quality of diabetes care do not include modern approaches to diabetes management, such as CGM. Continuous glucose monitors rival traditional methods of measuring diabetes management by providing real-time, longitudinal data and demonstrating glucose variability over time. The Improving Diabetes Quality Initiative seeks to address this gap in diabetes quality measurement. Methods: A Technical Expert Panel (TEP) was convened to curate a diabetes quality measures portfolio and conceptualize three new CGM-related quality measures within the portfolio. From the additional measure concepts identified in the portfolio, the TEP prioritized three for conceptualization. High-level measure concept specifications were made available during a public comment period. Results: The measure concepts prioritized by the TEP included a shared decision-making measure to assess the value of initiating CGM for disease management, a utilization measure to address disparities in access and use of CGM, and a patient-provider review of CGM data to promote routine consideration of these assessments in treatment and ongoing management. Clinical literature, public comments, and TEP feedback informed full measure specifications. Conclusions: The evolution of diabetes technology reflects the need to shift diabetes quality of care. The measure concepts will be tested in a flexible pilot setting to understand the future of diabetes care and communicate the value of CGM to people with diabetes, providers, and payers.